13-37637219-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_016179.4(TRPC4):c.2618G>A(p.Arg873His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000272 in 1,613,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRPC4 | NM_016179.4 | c.2618G>A | p.Arg873His | missense_variant | 11/11 | ENST00000379705.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRPC4 | ENST00000379705.8 | c.2618G>A | p.Arg873His | missense_variant | 11/11 | 1 | NM_016179.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000159 AC: 40AN: 250844Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135602
GnomAD4 exome AF: 0.000283 AC: 413AN: 1461632Hom.: 0 Cov.: 31 AF XY: 0.000292 AC XY: 212AN XY: 727108
GnomAD4 genome AF: 0.000171 AC: 26AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.2633G>A (p.R878H) alteration is located in exon 11 (coding exon 10) of the TRPC4 gene. This alteration results from a G to A substitution at nucleotide position 2633, causing the arginine (R) at amino acid position 878 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at